Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients

The purpose of this work was to determine whether changes in cholesterol profiles after interferon-β (IFN-β)1a treatment initiation following the first demyelinating event suggestive of multiple sclerosis are associated with clinical and MRI outcomes over 4 years. A group of 131 patients (age: 27.9...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Lipid Res
Autors principals: Uher, Tomas, Fellows, Kelly, Horakova, Dana, Zivadinov, Robert, Vaneckova, Manuela, Sobisek, Lukas, Tyblova, Michaela, Seidl, Zdenek, Krasensky, Jan, Bergsland, Niels, Weinstock-Guttman, Bianca, Havrdova, Eva, Ramanathan, Murali
Format: Artigo
Idioma:Inglês
Publicat: The American Society for Biochemistry and Molecular Biology 2017
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5282956/
https://ncbi.nlm.nih.gov/pubmed/27923871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M072751
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars